Antev Ltd.
Clinical trials sponsored by Antev Ltd., explained in plain language.
-
One-shot hormone blocker may prevent repeat urinary blockages in men
Disease control Not yet recruitingThis phase 2 trial tests whether a single injection of teverelix DP, a hormone-blocking drug, can shrink the prostate and improve urinary function in men who recently experienced a first episode of acute urinary retention due to an enlarged prostate. About 126 men aged 45 and old…
Phase: PHASE2 • Sponsor: Antev Ltd. • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New drug aims to starve prostate cancer by blocking testosterone
Disease control Not yet recruitingThis phase 2 trial tests a drug called teverelix DP in 40 men with advanced prostate cancer. The drug works by blocking a hormone that tells the body to make testosterone, which can fuel cancer growth. The goal is to see if a specific dosing schedule can safely lower testosterone…
Phase: PHASE2 • Sponsor: Antev Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC